References
Bradshaw D, Hill CH, Nixon JS, Wilkinson SE. Therapeutic potential of protein kinase C inhibitors. Agents Actions 1993;38:135–47.
Berry N, Nishizuka Y. Protein kinase C and T cell activation. Eur J Biochem 1990;189:205–14.
Birchall AM, Bishop J, Bradshaw D, Cline A, Coffey J, Elliot LH, et al. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J Pharmacol Exp Ther 1994;268:922–9.
Prabhakar U, Lipshutz D, Pullen M, Turchin H, Kassis S, Nambi P. Protein kinase C regulates TNF-α production by human monocytes. Eur Cytokine Netw 1993;4:31–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DiMartino, M., Wolff, C., Patil, A. et al. Effects of a protein kinase C inhibitor (PKCI) on the development of adjuvant-induced arthritis (AA) in rats. Inflamm Res 44 (Suppl 2), S123–S124 (1995). https://doi.org/10.1007/BF01778293
Issue Date:
DOI: https://doi.org/10.1007/BF01778293